|
|
Three Months
ended March 31,
|
|
|
|
2021
|
2020
|
|
|
Amount
|
Amount
|
|
|
|
|
|
Net
income:
|
$545
|
$226
|
|
Adjustments:
|
|
|
|
Depreciation and
amortization
|
285
|
374
|
|
Interest
income
|
(1)
|
(58)
|
|
Income tax
expense
|
163
|
80
|
|
EBITDA:
|
$992
|
$622
|
|
|
Three Months
ended March 31,
|
|||
|
|
2021
|
2020
|
||
|
|
Amount
|
Per diluted
share
|
Amount
|
Per diluted
share
|
|
|
|
|
|
|
|
Net
income:
|
$545
|
$0.14
|
$226
|
$0.06
|
|
Adjustments:
|
|
|
|
|
|
Amortization of
intangible assets (1)
|
117
|
0.03
|
172
|
0.04
|
|
Stock-based
compensation (2)
|
63
|
0.02
|
45
|
0.01
|
|
Tax impact of
adjustments (3)
|
(38)
|
(0.01)
|
(46)
|
(0.01)
|
|
Non-GAAP net
income:
|
$687
|
$0.18
|
$397
|
$0.10
|
|
|
March 31,
|
December 31,
|
|
|
2021
|
2020
|
|
ASSETS
|
(unaudited)
|
|
|
Current
assets:
|
|
|
|
Cash
and cash equivalents
|
$20,548
|
$19,556
|
|
Accounts
receivable (net of allowance for doubtful accounts of $651 and
$657, respectively)
|
2,966
|
2,514
|
|
Other
current assets
|
383
|
298
|
|
Total
current assets
|
23,897
|
22,368
|
|
Capitalized
software (net of accumulated amortization of $2,893 and $2,761,
respectively)
|
394
|
526
|
|
Fixed
assets (net of accumulated amortization of $348 and $312,
respectively)
|
775
|
795
|
|
Right-of-use asset
– leases
|
1,756
|
1,830
|
|
Other
long-term assets
|
93
|
88
|
|
Goodwill
|
6,376
|
6,376
|
|
Intangible
assets (net of accumulated amortization of $5,663 and $5,546,
respectively)
|
2,789
|
2,906
|
|
Total assets
|
$36,080
|
$34,889
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
Current
liabilities:
|
|
|
|
Accounts
payable
|
$589
|
$304
|
|
Accrued
expenses
|
2,098
|
1,805
|
|
Income
taxes payable
|
358
|
258
|
|
Deferred
revenue
|
2,383
|
2,212
|
|
Total
current liabilities
|
5,428
|
4,579
|
|
Deferred
income tax liability
|
262
|
197
|
|
Lease liabilities
– long-term
|
1,890
|
1,971
|
|
Total liabilities
|
7,580
|
6,747
|
|
Commitments
and contingencies
|
|
|
|
Stockholders'
equity:
|
|
|
|
Preferred
stock, $0.001 par value, 1,000,000 shares authorized, no shares
issued and outstanding as of March 31, 2021 and December 31, 2020,
respectively.
|
—
|
—
|
|
Common stock $0.001 par value,
20,000,000 shares authorized, 3,765,975 and 3,770,752 shares issued and outstanding as
of March 31, 2021 and December 31, 2020,
respectively.
|
4
|
4
|
|
Additional
paid-in capital
|
22,024
|
22,214
|
|
Other
accumulated comprehensive loss
|
(16)
|
(19)
|
|
Retained
earnings
|
6,488
|
5,943
|
|
Total stockholders' equity
|
28,500
|
28,142
|
|
Total liabilities and stockholders’ equity
|
$36,080
|
$34,889
|
|
|
For the Three
Months Ended
|
|
|
|
March
31,
|
March
31,
|
|
|
2021
|
2020
|
|
|
|
|
|
Revenues
|
$4,980
|
$4,016
|
|
Cost of
revenues
|
1,394
|
1,253
|
|
Gross
profit
|
3,586
|
2,763
|
|
Operating costs and
expenses:
|
|
|
|
General and
administrative
|
1,404
|
1,216
|
|
Sales and marketing
expenses
|
1,074
|
896
|
|
Product
development
|
249
|
194
|
|
Depreciation and
amortization
|
152
|
209
|
|
Total operating
costs and expenses
|
2,879
|
2,515
|
|
Operating
income
|
707
|
248
|
|
Interest income,
net
|
1
|
58
|
|
Net income before
income taxes
|
708
|
306
|
|
Income tax
expense
|
163
|
80
|
|
Net
income
|
$545
|
$226
|
|
Income per share
– basic
|
$0.15
|
$0.06
|
|
Income per share
– fully diluted
|
$0.14
|
$0.06
|
|
Weighted average
number of common shares outstanding – basic
|
3,769
|
3,788
|
|
Weighted average
number of common shares outstanding – fully
diluted
|
3,817
|
3,824
|
|
|
For the Three Months Ended
|
|
|
|
March 31,
|
March 31,
|
|
|
2021
|
2020
|
|
Cash flows from operating activities:
|
|
|
|
Net
income
|
$545
|
$226
|
|
Adjustments
to reconcile net income to net cash provided by operating
activities:
|
|
|
|
Depreciation
and amortization
|
285
|
374
|
|
Bad
debt expense
|
28
|
93
|
|
Deferred
income taxes
|
(15)
|
(42)
|
|
Non-cash
interest expense
|
—
|
6
|
|
Stock-based
compensation expense
|
63
|
45
|
|
Changes
in operating assets and liabilities:
|
|
|
|
Decrease
(increase) in accounts receivable
|
(484)
|
(219)
|
|
Decrease
(increase) in other assets
|
(16)
|
32
|
|
Increase
(decrease) in accounts payable
|
287
|
118
|
|
Increase
(decrease) in accrued expenses
|
398
|
(105)
|
|
Increase
(decrease) in deferred revenue
|
178
|
74
|
|
Net
cash provided by operating activities
|
1,269
|
602
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
Purchase
of fixed assets
|
(16)
|
—
|
|
Net
cash used in investing activities
|
(16)
|
—
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
Exercise
of stock options
|
199
|
—
|
|
Payment
for stock repurchase and retirement
|
(452)
|
(203)
|
|
Net
cash used in financing activities
|
(253)
|
(203)
|
|
|
|
|
|
Net
change in cash and cash equivalents
|
1,000
|
399
|
|
Cash
– beginning
|
19,556
|
15,766
|
|
Currency
translation adjustment
|
(8)
|
32
|
|
Cash
and cash equivalents – ending
|
$20,548
|
$16,197
|
|
|
|
|
|
Supplemental disclosures:
|
|
|
|
Cash
paid for income taxes
|
$—
|
$10
|